India, Sept. 24 -- The U.S. FDA has placed a new thyroid medication recall in the most dangerous category after testing verified that one lot of Vitruvias Therapeutics' Thyroid Tablets USP 30mg could potentially be super potent, as it might have higher thyroid hormone levels than usual. The recall includes one lot that was distributed all over America, and the FDA reiterated that excess thyroid hormone exposure may lead to serious health problems.

Why did the FDA raise the thyroid medicine recall to Class I?

On September 22, the FDA classified the recall as Class I, its highest-risk recall category. The agency uses this classification when there is a reasonable probability that exposure to a recalled product could cause serious adverse ...